The Hill: In War on Cancer, Patients at Risk of Becoming Commoditized
Ted Okon, executive director of the Community Oncology Alliance, highlights the significant progress the medical community has made in the war on cancer but stresses the importance of access to care to...
View ArticleClik here to view.
Biotech CEOs Talk JOBS Act and IPO Experiences at 2014 BIO Investor Forum
The JOBS Act has contributed to a dramatic acceleration in new biotech IPOs since its passage, with nearly a tripling in the rate of companies going public in the industry. By changing how...
View ArticleTony Coelho: A Patient Advocate’s Perspective on Paying for Value
Yesterday, Health Affairs published an op-ed by Tony Coelho, Former Member of the U.S. House of Representatives and Chairman of the Partnership to improve patient care, on the benefit of...
View ArticleCenter for Medicine in the Public Interest Challenges Accuracy of 60 Minutes...
This week, the Center for Medicine in the Public Interest issued a press release criticizing CBS’ “60 Minutes” segment on cancer treatment prices as not just distorted but ‘dead wrong.’ “Featuring...
View ArticleClik here to view.
Patent Cases Down by 40% in 2014
The number of new patent cases filed in federal court has dropped by an astonishing 40 percent as compared to this time last year. This trend has some questioning whether Congressional patent reform is...
View ArticleMilwaukee Journal Sentinel Story on Use of Surrogate Measures
Earlier this week, John Fauber of the Milwaukee Journal Sentinel wrote an article on measures used to determine whether new medicines for serious and life-threatening diseases should reach patients....
View ArticleClik here to view.
Indian Patents Ensure Wide Access to Drugs, Without Raising Prices
Two recent studies on Indian drugs have shown that patent protection does not dramatically increase prices, but does ensure widespread access to life saving therapeutics. This research confirms that a...
View ArticleClik here to view.
Now What is Patentable?
On Tuesday of the Pacific Rim Summit, experts from Knobbe Martens, BIO, and Synthetic Genomics explored the legal, policy and business implications of the Myriad decision, the United States Patent and...
View ArticleNew York Legislators to PTO Head: Stop IPR Abuse
This week ten members the U.S. House of Representatives from New York wrote to U.S. Patent and Trademark Office Director Michelle K. Lee to express concern with continued abuse of the inter partes...
View ArticleClik here to view.
HHS Secretary Azar Calls for Strengthened Global Health Through Innovation
Last week Health and Human Services Secretary Alex Azar spoke in Geneva at the 71st World Health Assembly’s meeting. While laying out key priorities for the US and the World Health Organization (WHO),...
View Article
